196 related articles for article (PubMed ID: 27263239)
21. Entrepreneurship.
Yetisen AK; Volpatti LR; Coskun AF; Cho S; Kamrani E; Butt H; Khademhosseini A; Yun SH
Lab Chip; 2015; 15(18):3638-60. PubMed ID: 26245815
[TBL] [Abstract][Full Text] [Related]
22. Results from an exploratory study to identify the factors that contribute to success for UK medical device small- and medium-sized enterprises.
Hourd PC; Williams DJ
Proc Inst Mech Eng H; 2008 Jul; 222(5):717-35. PubMed ID: 18756690
[TBL] [Abstract][Full Text] [Related]
23. Barriers to Alzheimer disease drug discovery and development in the biotechnology industry.
Altstiel LD
Alzheimer Dis Assoc Disord; 2002; 16 Suppl 1():S29-32. PubMed ID: 12070359
[TBL] [Abstract][Full Text] [Related]
24. Medipol: the guardian angel of biologics.
Laue C; Ruppanner V
Nanomedicine (Lond); 2006 Aug; 1(2):251-4. PubMed ID: 17716114
[TBL] [Abstract][Full Text] [Related]
25. Genetic Counselors in Startup Companies: Redefining the Genetic Counselor Role.
Rabideau MM; Wong K; Gordon ES; Ryan L
J Genet Couns; 2016 Aug; 25(4):649-57. PubMed ID: 26801784
[TBL] [Abstract][Full Text] [Related]
26. Making it in the biotech business.
Gewin V
Nature; 2005 May; 435(7038):124-5. PubMed ID: 15875029
[No Abstract] [Full Text] [Related]
27. Exploring business models for managing uncertainty in healthcare, medical devices, and biotechnology industries.
Javanmardi E; Maresova P; Xie N; Mierzwiak R
Heliyon; 2024 Feb; 10(4):e25962. PubMed ID: 38370194
[TBL] [Abstract][Full Text] [Related]
28. How much do physician-entrepreneurs contribute to new medical devices?
Smith SW; Sfekas A
Med Care; 2013 May; 51(5):461-7. PubMed ID: 23358387
[TBL] [Abstract][Full Text] [Related]
29. The biotechnology sector in a latecomer country: The case of Poland.
Szczygielski K; Lewkowicz J; Michałek JJ
N Biotechnol; 2022 May; 68():97-107. PubMed ID: 35104636
[TBL] [Abstract][Full Text] [Related]
30. Exploitation of biotechnology in a large company.
Dart EC
Philos Trans R Soc Lond B Biol Sci; 1989 Aug; 324(1224):599-611. PubMed ID: 2573093
[TBL] [Abstract][Full Text] [Related]
31. Attitudes of employees of service and trading companies towards people with epilepsy and their professional activity in Poland.
Dorota T; Witkowska M; Michalak M
Seizure; 2014 Mar; 23(3):178-83. PubMed ID: 24332504
[TBL] [Abstract][Full Text] [Related]
32. Biomedical technology in Franconia.
Efferth T
Arzneimittelforschung; 2000 Jan; 50(1):93-7. PubMed ID: 10683721
[TBL] [Abstract][Full Text] [Related]
33. Biopharma business models in Canada.
March-Chordà I; Yagüe-Perales RM
Drug Discov Today; 2011 Aug; 16(15-16):654-8. PubMed ID: 21708279
[TBL] [Abstract][Full Text] [Related]
34. The hidden dragons.
Zeng M; Williamson PJ
Harv Bus Rev; 2003 Oct; 81(10):92-9, 137. PubMed ID: 14521101
[TBL] [Abstract][Full Text] [Related]
35. Novel approaches to innovation in medical device manufacture.
McKay I
Med Device Technol; 2004 Jun; 15(5):24-6. PubMed ID: 15285484
[TBL] [Abstract][Full Text] [Related]
36. Translating Science Into Business Innovation: The Case of Open Food and Nutrition Data Hackathons.
Tucci C; Viscusi G; Gautschi H
Front Nutr; 2018; 5():96. PubMed ID: 30406107
[TBL] [Abstract][Full Text] [Related]
37. Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s).
Hu H; Chung CC
Int J Health Policy Manag; 2015 Sep; 4(12):823-9. PubMed ID: 26673466
[TBL] [Abstract][Full Text] [Related]
38. From bench to business and back again.
Wilan K
Cell; 2007 Oct; 131(2):211-3. PubMed ID: 17956718
[TBL] [Abstract][Full Text] [Related]
39. Why foreign STEM PhDs are unlikely to work for US technology startups.
Roach M; Skrentny J
Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16805-16810. PubMed ID: 31383762
[TBL] [Abstract][Full Text] [Related]
40. [Commercialization of genetic research and its impact on the communication of results].
Cardinal G
Health Law J; 1999; 7():35-48, 33. PubMed ID: 11066367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
